Although the influenza 2009 H1N1 vaccine produced by Novartis, Fluvirin, was previously approved for use in the US, the clinical data supporting its safety and immunogenicity had not been released. The company has now issued a media release containing interim clinical data on the effects of the vaccine in humans. ...

I have had many opportunities to speak with journalists of different kinds during the more than 30 years that I have studied viruses. I wrote previously about my negative experience with CNN. I'd like to relate a much more positive encounter with newspaper reporters. As a postdoctoral fellow in David ...

The emergence of oseltamivir (Tamiflu)-resistant 2009 H1N1 influenza virus in a Canadian family illustrates the basic concept that viral loads depend on the dose of antiviral drug. Neuraminidase inhibitors like Tamiflu and Relenza are used to treat severe illness caused by the 2009 pandemic influenza A (H1N1) virus. The antiviral ...

GlaxoSmithKline's inactivated 2009 influenza H1N1 vaccine has been approved by the US Food & Drug Administration and by Health Canada. This action completes the list of pandemic H1N1 vaccines which I previously summarized for the US and Canada. Influenza A (H1N1) 2009 monovalent vaccine is produced by ID Biomedical Corporation ...

Hosts: Vincent Racaniello, Dick Despommier, Alan Dove, and Joshua Stillman In episode 58 of the podcast "This Week in Virology", Vincent, Dick, and Alan are joined by emergency medicine physician Dr. Joshua Stillman to talk about passive antibody therapy for Nipah infection in ferrets, annual influenza immunization of children, facemasks ...